Pharmacokinetic profile of Myfortic (enteric coated mycophenolate sodium) in a rapid steroid withdrawal protocol in combination with tacrolimus in stable renal transplant recipients in the fed and fasting state
Phase of Trial: Phase IV
Latest Information Update: 09 May 2016
At a glance
- Drugs Mycophenolate sodium; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 11 Mar 2011 Planned end date changed from Dec 2008 to Jul 2011 as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.